PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma
Clinical trial NCT07209059 · RECRUITING
Trial details
- NCT number
- NCT07209059
- Sponsor
- National Research Center for Hematology, Russia
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-29
- Primary completion
- 2027-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.